| Castration-Resistant Prostate Carcinoma studied in …STUDIED_INderived200 of 553show all (up to 200) |
|---|
| → studied in | NCT05081193Phase 2 · active not recruiting Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer · condition mapped ALIAS · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06738303Phase 2 · recruiting Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07667400Phase 1/Phase 2 · not yet recruiting Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06031805active not recruiting PRostate Olaparib Real World Evidence Study · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07594106Phase 1/Phase 2 · recruiting REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02123758Phase 1 · active not recruiting A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03460977Phase 1 · recruiting A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03568656Phase 1/Phase 2 · completed Study to Evaluate CCS1477 in Advanced Tumours · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04071236Phase 1/Phase 2 · suspended Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal Therapy · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06136650Phase 3 · recruiting A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004) · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06629779Phase 3 · recruiting A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer. · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06801236Phase 1 · recruiting Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06052306Phase 1 · active not recruiting A Study to Learn How Safe the Study Treatment Actinium-225-macropa-pelgifatamab (BAY3546828) is, How it Affects the Body, How it Moves Into, Through and Out of the Body, and About Its Anticancer Activity in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC) · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06836726Phase 2 · not yet recruiting Clinical Trial to Test Efficacy of Targeting Hypoxia Combined With ARSI After First-line ARSI Therapy for Castrate Resistant Prostate Cancer · condition mapped ALIAS · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07719361Phase 1 · recruiting A Study in Patients With Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05489211Phase 2 · recruiting Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06894511Phase 2 · active not recruiting An Open-label Study of Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI Versus AAA617 in PSMA Positive First-line mCRPC · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07213674Phase 3 · recruiting A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07570979Phase 1 · recruiting A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07824349Phase 1 · recruiting JUR-003 in Adult Patients With Metastatic Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04104893Phase 2 · active not recruiting A Study of CHeckpoint Inhibitors in Men With prOgressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 Inactivation · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04615845Phase 1 · terminated A Phase 1 Study of Autologous Dendritic Cell Immunotherapy in Patients With mCRPC · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05521412Phase 1/Phase 2 · recruiting EValuation of radIOLigand Treatment in mEn With Metastatic Castration-resistant Prostate Cancer With [161Tb]Tb-PSMA-I&T · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07365995Phase 3 · recruiting A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05011188Phase 1/Phase 2 · active not recruiting FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07813637Phase 1 · recruiting Phase 1 Trial to Study JANX013 and JANX007 Combination in mCRPC · condition mapped ALIAS · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06380738active not recruiting Real-World Clinical Experience of Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Olaparib + Abiraterone (PROceed) · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07549256Phase 2 · recruiting Cannabidiol for Pain Relief of Patients With End-stage mCRPC · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07608718Phase 2 · not yet recruiting Phase II Trial of Zanzalitinib in Patients With Metastatic Castration Resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02522715Phase 1/Phase 2 · active not recruiting Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer · condition mapped ONTOLOGY_EXACT · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05670106Phase 2 · completed A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Dosimetry of [177Lu]Lu-PSMA-617 in Chinese Adult Male Patients With Progressive PSMA-Positive mCRPC · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07493512Phase 1 · recruiting Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07581184Phase 1 · recruiting A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02703623Phase 2 · active not recruiting Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer · condition mapped ONTOLOGY_EXACT · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05762536Phase 2 · recruiting Docetaxel or Cabazitaxel With or Without Darolutamide in mCRPC · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05766371Phase 2 · recruiting Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06100705Phase 2 · recruiting Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03317392Phase 1/Phase 2 · active not recruiting Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone Metastasis · condition mapped ONTOLOGY_EXACT · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04592237Phase 2 · active not recruiting Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer · condition mapped ONTOLOGY_EXACT · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05502315Phase 2 · active not recruiting Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer · condition mapped ALIAS · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06764485Phase 3 · active not recruiting A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07803653Phase 1 · not yet recruiting IL-18 Armored STEAP1 CAR T Cells for the Treatment of Metastatic Castration Resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06909825Phase 2 · active not recruiting FPI-2265 (225Ac-PSMA-I&T) and Olaparib for Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07005154Phase 2 · recruiting A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07285694Phase 1/Phase 2 · active not recruiting AB-3028, a Programmable Circuit T Cell Therapy in Patients With Castration Resistant Prostate Cancer (CRPC) · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07287150Phase 2 · recruiting A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07545811Phase 1 · recruiting Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07723248Phase 3 · recruiting A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1) · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06632977Phase 2 · recruiting Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial · condition mapped ONTOLOGY_EXACT · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07200830Phase 3 · recruiting Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07609225early Phase 1 · not yet recruiting Chemical-Shift-Encoded MRI for Active Bone Marrow Dosimetry in Radiopharmaceutical Therapy · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07798778early Phase 1 · recruiting Clinical Evaluation of SRT-017 in Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05171816Phase 3 · active not recruiting Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer (China Cohort) · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07218666Phase 2 · recruiting Zanzalintinib in Men With Aggressive Variant Prostate Cancer · condition mapped ONTOLOGY_EXACT · 553 trials mapped (237 active) | — | — | Aggressive Variant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07698535Phase 2 · recruiting Measuring Circulating Tumor Deoxyribonucleic Acid Tumor Fraction to Guide Early 177Lu-PSMA-617 Treatment Discontinuation in Patients With Metastatic Castration-Resistant Prostate Cancer, DYNAMO Trial · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03442556Phase 2 · terminated Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency · condition mapped ONTOLOGY_EXACT · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04090528Phase 2 · active not recruiting pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer · condition mapped ALIAS · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04631601Phase 1/Phase 2 · terminated Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate Cancer (mCRPC) · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07611110Phase 3 · recruiting AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01) · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04019327Phase 1/Phase 2 · terminated A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer · condition mapped ALIAS · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07745361Phase 2 · recruiting Study of Oral MRT-2359 With Apalutamide in Prostate Cancer · condition mapped ALIAS · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05805371Phase 1 · recruiting PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate Cancer · condition mapped ONTOLOGY_EXACT · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06844383Phase 2 · recruiting A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06200103Phase 2 · suspended Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer · condition mapped ONTOLOGY_EXACT · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06785636Phase 1/Phase 2 · recruiting A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04104776Phase 1/Phase 2 · recruiting A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04550494Phase 2 · active not recruiting Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations · condition mapped ONTOLOGY_EXACT · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03732820Phase 3 · active not recruiting Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06966024Phase 1 · recruiting Study of DCC-2812 in Participants With Advanced Genitourinary Cancers · condition mapped ALIAS · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05919264Phase 1/Phase 2 · recruiting FOG-001 in Locally Advanced or Metastatic Solid Tumors · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06842498Phase 2 · recruiting A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05519449Phase 1 · recruiting Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01) · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04489719recruiting Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer · condition mapped ONTOLOGY_EXACT · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05613894Phase 1 · recruiting Dose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06236139Phase 1/Phase 2 · recruiting Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06067841Phase 1 · recruiting A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06305598Phase 1 · active not recruiting Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer · condition mapped ONTOLOGY_EXACT · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03419234Phase 2 · active not recruiting Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel · condition mapped ONTOLOGY_EXACT · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06145633Phase 2 · recruiting Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer · condition mapped ONTOLOGY_EXACT · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05176483Phase 1 · recruiting Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02893917Phase 2 · active not recruiting Testing Two Oral Drugs Combination (Cediranib and Olaparib) Compared to a Single Drug (Olaparib) for Men With Advanced Prostate Cancer · condition mapped ONTOLOGY_EXACT · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03517969Phase 2 · active not recruiting M6620 and Carboplatin With or Without Docetaxel in Treating Patients With Metastatic Castration-Resistant Prostate Cancer · condition mapped ONTOLOGY_EXACT · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05828082Phase 2 · active not recruiting Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer · condition mapped ONTOLOGY_EXACT · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07288359Phase 1/Phase 2 · recruiting Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07096999recruiting SPECT/CT Imaging for Dosimetry in 177Lu-PSMA-617 (Pluvicto) Therapy · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05113537Phase 1/Phase 2 · recruiting Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer · condition mapped ONTOLOGY_EXACT · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04471974Phase 2 · active not recruiting ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer · condition mapped ONTOLOGY_EXACT · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06228404early Phase 1 · active not recruiting Clinical Study of Safety and Efficacy of Enhanced PSMA CAR- T in Refractory CRPC · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06895811Phase 1 · active not recruiting Clinical Study of Safety and Efficacy of Universal PSMA CAR- T in Refractory CRPC · condition mapped ALIAS · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06942104Phase 1 · recruiting Imaging of Solid Tumors Using 18F-TRX · condition mapped ONTOLOGY_EXACT · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07641855Phase 2/Phase 3 · not yet recruiting A Study of BL-B01D1 Combination Therapy in Patients With Metastatic Castration-resistant Prostate Cancer · condition mapped ALIAS · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05689021Phase 2 · terminated CJNJ-67652000 and Prednisone for Treatment of Metastatic Castration-Resistant Prostate Cancer and SPOP Gene Mutations · condition mapped ONTOLOGY_EXACT · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04549207Phase 4 · active not recruiting Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer · condition mapped ALIAS · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06039371Phase 2 · recruiting Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study · condition mapped ONTOLOGY_EXACT · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06520345Phase 3 · recruiting The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global) · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06378866Phase 2 · recruiting Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial · condition mapped ALIAS · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02861573Phase 1/Phase 2 · active not recruiting Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365) · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06517719recruiting Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06004661Phase 2 · active not recruiting Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal Function · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03972657Phase 1/Phase 2 · recruiting A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07103018Phase 1 · recruiting A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001) · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06029998Phase 2 · active not recruiting Bortezomib in Patients With Metastatic Castration-Resistant Prostate Cancer With PTEN Deletion · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06217822Phase 1 · recruiting First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC) · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06526299Phase 2 · recruiting Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06514521recruiting Post Marketing Study on Pluvicto in Korea · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07682649Phase 1 · not yet recruiting Escalating Cycle 1 Dose of Lu-177-PSMA-617 for the Treatment of Metastatic Castration Resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07683013Phase 1 · not yet recruiting Safety, Tolerability, and Efficacy of CP-PCA07 in Combination With Enzalutamide in Patients With Castration-Resistant Prostate Cancer · condition mapped ALIAS · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06401980Phase 2 · recruiting Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC) · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06568562Phase 2 · recruiting XL092 in Patients With Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07674121not yet recruiting PROLONG (PRostateOLaparibONcombinationGcc) Study · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03641560Phase 4 · completed A Safety and Efficacy Study of Enzalutamide in Indian Patients With Progressive Metastatic Castration-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel-Based Chemotherapy · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06533644Phase 2 · recruiting A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04419402Phase 2 · active not recruiting Enzalutamide With Lu PSMA-617 Versus Enzalutamide Alone in Men With Metastatic Castration-resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07570966Phase 1/Phase 2 · withdrawn Study of ERW316 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07658573active not recruiting AI Multimodal Model for Predicting CRPC Progression Risk · condition mapped ALIAS · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06922318Phase 2 · recruiting The COSMYC Trial (COmbined Suppression of MYC) · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07503808Phase 1 · recruiting A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types · condition mapped ALIAS · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04751929Phase 2 · completed Abemaciclib With or Without Atezolizumab for mCRPC · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06318273Phase 1 · active not recruiting A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07540572Phase 1 · recruiting A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors · condition mapped ALIAS · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05398302Phase 1 · recruiting Image-Guided Biopsies to Identify Mechanisms of Resistance in Patients With Metastatic Castration Resistant Prostate Cancer Treated With 177Lu-PSMA Radioligand Therapy · condition mapped ONTOLOGY_EXACT · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03652493Phase 2 · completed Trial Evaluating the Efficacy of CARBOPLATIN in Metastatic Prostate Cancer With Gene Alterations in the Homologous Recombination Pathway · condition mapped ALIAS · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05283330Phase 1 · recruiting Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07641049Phase 1 · recruiting Dual-target PSMA/PSCA CAR-NK Cells in Advanced Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05730712Phase 2 · completed Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate Cancer · condition mapped ONTOLOGY_EXACT · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05168618Phase 2 · recruiting Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer · condition mapped ONTOLOGY_EXACT · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06609005Phase 1/Phase 2 · recruiting A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03344211Phase 2 · active not recruiting Enzalutamide With or Without Radium Ra 223 Dichloride in Patients With Metastatic, Castration-Resistant Prostate Cancer · condition mapped ONTOLOGY_EXACT · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07623460Phase 2 · not yet recruiting Zanzalintinib Efficacy Post Pluvicto® in Chemotherapy Naïve Metastatic Castration Resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03873805Phase 1 · active not recruiting PSCA-CAR T Cells in Treating Patients With PSCA+ Metastatic Castration Resistant Prostate Cancer · condition mapped ONTOLOGY_EXACT · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06228053Phase 2 · recruiting Study of SX-682 Plus Enzalutamide in Men With ARPI-Resistant Metastatic Castration Resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07621692Phase 1 · recruiting Exploring Auger-Enhanced PSMA-Targeted Radioligand Therapy: A First-in-Taiwan Clinical Study of 161Tb-PSMA-I&T · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04109729Phase 1 · active not recruiting Study of Nivolumab in Combination w Radium-223 in Men w Metastatic Castration Resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07344311Phase 1 · recruiting A Phase I Trial of A-CAR032 in Participants With mCRPC · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04514484Phase 1 · active not recruiting Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV · condition mapped ONTOLOGY_EXACT · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04070209Phase 2 · active not recruiting Management of Oligoprogressive Castration Resistant Prostate Cancer (PCS X) · condition mapped ALIAS · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05806814Phase 1 · active not recruiting Sipuleucel-T Based Autologous Cellular Immunotherapy for Advanced Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06492122Phase 1 · recruiting Study With [225Ac]Ac-FL-020 in mCRPC Participants · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05682443Phase 1/Phase 2 · active not recruiting ONC-392 Plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients With mCRPC · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07189403Phase 1 · recruiting A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07240857early Phase 1 · enrolling by invitation A Clinical Study Evaluating the Safety and Efficacy of Local Injection of ACT#001 Chimeric Antigen Receptor T Cells in the Treatment of Castration-Resistant Prostate Cancer · condition mapped ALIAS · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04388852Phase 1 · active not recruiting DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell Cancers · condition mapped ONTOLOGY_EXACT · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03437941Phase 1/Phase 2 · terminated Study to Evaluate Exicorilant (CORT125281) in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04716725Phase 2 · terminated 68Ga-PSMA-11 PET for the Diagnosis of Metastatic Castration Resistant Prostate Cancer · condition mapped ONTOLOGY_EXACT · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06691984Phase 3 · active not recruiting Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute) · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07093801recruiting Observational Study on Lutetium (177Lu) Vipivotide Tetraxetan to Treat Metastatic Castration Resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07244341Phase 1 · recruiting A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC) · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07476001Phase 2 · recruiting Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPC · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02312557Phase 2 · active not recruiting Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Enzalutamide · condition mapped ONTOLOGY_EXACT · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04769817active not recruiting ProsTIC Registry of Men Treated With PSMA Theranostics · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05413850Phase 1/Phase 2 · recruiting Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07583160Phase 1 · enrolling by invitation YS247 (Neoantigen-Pulsed DC Vaccine) for Metastatic Prostate Cancer · condition mapped ALIAS · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04846478Phase 1 · active not recruiting Phase Ia/Ib Talazoparib + Tazemetostat for mCRPC · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06879041Phase 1 · recruiting A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04986423Phase 2 · recruiting ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07025512Phase 2 · withdrawn 177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07414940Phase 1/Phase 2 · recruiting ACTinium in Castrate-RESistant Prostate Cancer After LUTEtium · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03217747Phase 1/Phase 2 · active not recruiting Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies · condition mapped ONTOLOGY_EXACT · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05005728Phase 2 · completed XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05125016Phase 1/Phase 2 · recruiting A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06616155Phase 1/Phase 2 · recruiting Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer · condition mapped ONTOLOGY_EXACT · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07451795Phase 2 · recruiting SHR-1701 in Combination With Stereotactic Body Radiotherapy in mCRPC · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03218826Phase 1 · completed PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07052760early Phase 1 · withdrawn Imaging of Solid Tumors Using DLL3 SPECT · condition mapped ALIAS · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07553988Phase 2 · active not recruiting A Comparative Dose-finding Study of RS-113 in Patients With Metastatic Castration-resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05588609Phase 2 · terminated Study Evaluating Zenocutuzumab in Patients With or Without Molecularly Defined Cancers · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06104449Phase 1 · completed A Study of Opevesostat (MK-568)4 in Japanese Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-005) · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06242509recruiting Intestinal Akkermansia Muciniphila in Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03522064Phase 2 · recruiting Bipolar Androgen Therapy + Carboplatin in mCRPC · condition mapped ALIAS · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03682289Phase 2 · active not recruiting Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02555189Phase 1/Phase 2 · terminated Enzalutamide With Ribociclib in Treating Patients With Metastatic Castrate-Resistant, Chemotherapy Naive Prostate Cancer That Retains Retinoblastoma Expression · condition mapped ONTOLOGY_EXACT · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05457257Phase 4 · active not recruiting Clinical Study to Assess the Efficacy and Safety of Olaparib in Chinese Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment With a New Hormonal Agent and Have BRCA1/2 Mutations · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07219147Phase 1 · recruiting 177^Lu-PSMA-617 in Combination With Sipuleucel-T for the Treatment of Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07537010Phase 1 · recruiting 3D1015 Injection for Patients With mCRPC · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06439225Phase 3 · recruiting Platinum and Taxane Chemo in Met Castration Resistant Prostate Cancer Patients With Alterations in DNA Damage Response Genes · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04693377NA · recruiting Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial · condition mapped ONTOLOGY_EXACT · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06615752Phase 1/Phase 2 · recruiting Green Tea and Quercetin in Combination With Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Patients · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05960578Phase 2 · active not recruiting Golimumab and Apalutamide for the Treatment of Castration-Resistant Prostate Cancer, TRAMP Study · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03869762Phase 2 · terminated Denosumab in Combination With Enzalutamide in Progressive Metastatic Castrate-resistant Prostate Cancer and Bone Metastases. · condition mapped ALIAS · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06190899Phase 1/Phase 2 · recruiting Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06610825Phase 2 · recruiting Castrate Resistant Prostate Cancer Enhertu Therapy · condition mapped ALIAS · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07192120Phase 1/Phase 2 · recruiting A Study of MHB048C in Patients With Advanced Solid Tumors · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06303713Phase 1 · active not recruiting LuCarbo - a Study of 177Lu-PSMA-617 Plus Carboplatin in Metastatic Castrate-resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06402331Phase 2 · active not recruiting FPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05219500Phase 2 · active not recruiting Targeted Alpha Therapy With 225Actinium-Prostate Specific Membrane Antigen (PSMA)-I&T of Castration-resISTant Prostate Cancer (TATCIST). · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02044354Phase 3 · completed Patient Preference Between Cabazitaxel and Docetaxel in Metastatic Castrate-resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07259213Phase 1/Phase 2 · recruiting A Study of Terbium 161 (161Tb)-RAD402 in Participants With CRPC · condition mapped ALIAS · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04853498Phase 1 · terminated A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3720 Tablets · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06193486Phase 1 · recruiting Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07189871Phase 1/Phase 2 · recruiting 177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors · condition mapped ALIAS · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05658003Phase 2 · active not recruiting A Study Evaluating [177Lu]Lu-PSMA-617 vs. a Change of Androgen Receptor-directed Therapy in Taxane Treatment Naive Chinese Male Patients With Progressive Metastatic Castrate Resistant Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06705686Phase 1 · recruiting Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06136598Phase 1 · completed A Study of Opevesostat (MK-5684) in China Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (MK-5684-001) · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05245006Phase 1 · active not recruiting PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05888532Phase 1/Phase 2 · recruiting 64Cu-GRIP B in Patients With Advanced Malignancies · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03360721Phase 2 · terminated Apalutamide, Abiraterone Acetate, and Prednisone in Treating Participants With Metastatic Castration Resistant Prostate Cancer · condition mapped ONTOLOGY_EXACT · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06288113Phase 2 · recruiting Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA Trial · condition mapped ONTOLOGY_EXACT · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06835218recruiting PROCARE - PROstate Cancer Real World Evidence Registry · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07142551Phase 2 · recruiting Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04179864Phase 1/Phase 2 · terminated A Study of Tazemetostat With Enzalutamide or Abiraterone/Prednisone in Participants With Advanced Prostate Cancer · condition mapped CURATED_BROADER · 553 trials mapped (237 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |